Medication info
Rinadafajing (Dapagliflozin Propanediol Monohydrate, Linagliptin)

Rinadafajing (Dapagliflozin Propanediol Monohydrate, Linagliptin)

Prescription medicationTablet
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Green Cross Corp.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets/box [7 tablets/PTP × 4], 30 tablets/bottle
Approval status
Active

MFDS item code 202400935 · Approved 2024.04.22

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who uses it
Adults
Adult dosage
For patients taking dapagliflozin 10 mg and linagliptin 5 mg, 1 tablet of this medication may be taken once daily, with or without food. Assessment of renal function is recommended before starting this medication and periodically during treatment. - If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or higher No dose adjustment based on renal function is necessary. - Use of this medication is not recommended if eGFR is less than 45 mL/min/1.73m2. No dosage adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment.

Ingredients

Manufacturer
Green Cross Corp.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used in conjunction with diet and exercise to improve blood sugar control in patients with type 2 diabetes. The combined effects of dapagliflozin and linagliptin help effectively regulate blood sugar levels. Taking this medication leads to better blood sugar control, significantly aiding in diabetes management.

Dosage and Administration

Adult dosage

For patients taking dapagliflozin 10 mg and linagliptin 5 mg, 1 tablet of this medication may be taken once daily, with or without food. Assessment of renal function is recommended before starting this medication and periodically during treatment. - If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or higher No dose adjustment based on renal function is necessary. - Use of this medication is not recommended if eGFR is less than 45 mL/min/1.73m2. No dosage adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment.

Precautions

This medication should not be used in certain patients. First, patients who are allergic to the main ingredients or additives of this medication should not take it. Second, patients with type 1 diabetes or diabetic ketoacidosis should not use this medication. Third, it is not administered to patients undergoing renal dialysis. Fourth, patients with myocardial infarction or those with a history of myocardial infarction should also avoid using this medication. Furthermore, caution should be exercised when administering this medication to patients with reduced fluid volume or impaired renal function. This medication can cause low blood pressure or worsening renal function, so such patients should have their fluid status and renal function carefully evaluated before taking it. During treatment, symptoms of hypotension or changes in renal function should be carefully monitored. When taken with other medications that can induce hypoglycemia, the risk of low blood sugar may increase, so it may be necessary to adjust the doses of insulin or insulin secretagogues. This medication experiences limited usage in patients with heart failure, especially those with severe heart failure, so caution is advised, and it is not recommended for patients with severe heart failure. Acute pancreatitis has been reported; therefore, if severe abdominal pain or other related symptoms occur during treatment, patients should stop taking the medication immediately and consult a physician. The development of bullous skin conditions similar to pemphigus may occur, so if blisters or skin irritation develop, the physician should be informed immediately. This medication can increase the risk of genital infections and urinary tract infections, so early treatment should be sought for any related symptoms. Elderly patients or those with diminished renal function have a higher risk of reduced fluid volume and hypotension, necessitating special caution. Pregnant or breastfeeding women should avoid taking this medication, and if pregnancy is confirmed, it should be discontinued immediately. During treatment, it is important to have regular blood tests and kidney function assessments for blood sugar control. In the case of overdose, there is no specific antidote; treatment should be administered according to the symptoms. While taking this medication, it is essential to periodically monitor health status and immediately consult medical professionals if unusual symptoms arise.

Side effects

hyperglycemia, constipation, diarrhea, dizziness, palpitations, weight loss, vulvar pruritus, hyperhidrosis, cystitis, urinary tract infection, thirst, diabetic ketoacidosis, vertigo, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, reduced creatinine clearance in the early treatment phase, dyslipidemia, elevated serum creatinine, elevated blood urea, vulvovaginitis, balanitis, fungal infection, perineal necrosis, hypoglycemia, decreased fluid volume, diabetic ketoacidosis, urinary tract infection, increased creatinine, perineal necrosis, acute pancreatitis, similar pemphigus, hypoglycemia, hypertriglyceridemia, hyperlipidemia, cough, pancreatitis, oral ulcer, rash, similar pemphigus, weight gain, increased lipase, increased amylase, constipation, upper abdominal pain, enterocolitis, bowel obstruction, gastritis, shingles, acute pyelonephritis, bronchitis, pneumonia, decreased appetite, dehydration, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, vertigo, renal transplant failure, anemia, headache, sensory loss, vaginal discharge, itching, insomnia, depression, hypertension, tinnitus, erectile dysfunction, goiter, food allergy, erythrocytosis, dyspepsia, nausea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, headache, nasopharyngitis, fatigue, hunger, vaginal discharge, urticaria, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, dry eye, cataract, dyspnea, orthostatic hypotension, insomnia, fatty liver, gallbladder polyp, vertigo, benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. Additionally, it is best stored at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets/box [7 tablets/PTP × 4], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.